MedCity News
JUNE 17, 2025
Robotics has already revolutionized fields like orthopedics and laparoscopic surgery. Endovascular care deserves the same leap forward. The technology exists. The evidence is strong. The challenge now is adoption. The post When Innovation Outpaces Adoption, Patients Pay the Price appeared first on MedCity News.
World of DTC Marketing
JUNE 19, 2025
Critics of direct-to-consumer (DTC) pharma advertising have called for a ban. They argue it misleads patients, drives up drug costs, and pushes people to pressure doctors for drugs they may not need. They’re not wrong about the consequences, but they’re also ignoring a core reality: DTC marketing isn’t going anywhere in the U.S. anytime soon. Why? Because too many influential players benefit from the status quo. 1.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 20, 2025
The FDA signed off on Gilead's twice-yearly HIV pre-exposure prophylaxis injection Yeztugo. With the nod, the drug becomes the longest-acting agent in HIV prevention.
PharmaVoice
JUNE 18, 2025
A new pilot program announced by FDA Commissioner Dr. Martin Makary would award vouchers that could cut drug reviews to one or two months — but only for products that meet a special criteria.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
JUNE 18, 2025
Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there’s excitement around other categories like AI agents and denials management, no other AI use case has achieved ambient scribes’ level of traction, noted Daniel Yang, Kaiser Permanente’s vice president of AI and emerging technologies.
World of DTC Marketing
JUNE 18, 2025
Bringing a new drug to market is a high-stakes game. After years of research, clinical trials, regulatory hurdles, and millions—if not billions—of dollars invested, launch day is supposed to mark the beginning of commercial success. Yet, many drugs fail to meet expectations out of the gate. When that happens, finger-pointing begins. But who bears the blame when a new drug flops at launch?
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
JUNE 19, 2025
The European Medicines Agency (EMA) has published a draft reflection paper that signals a potential evolution in the regulatory landscape for biosimilar development within the EU. 1 Rather than representing a radical break from established practice, the document builds on decades of scientific and regulatory experience, proposing that – under certain well-defined conditions – the demonstration of bio-similarity might rely more heavily on advanced analytical characterisation and pharmacokinetic (
MedCity News
JUNE 20, 2025
Draig Therapeutics’ lead drug is designed to safely target the AMPA receptor as a way of mediating the interplay between two neurotransmitters whose imbalance is associated with mood disorders. The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or entering clinical testing. The post Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs appeared first on MedCity News.
World of DTC Marketing
JUNE 15, 2025
Direct-to-consumer (DTC) pharmaceutical advertising is often caught in the crossfire of political debates. Senator Bernie Sanders, among other critics, has repeatedly asserted that DTC ads inflate healthcare costs by driving unnecessary prescriptions. But is this perspective supported by evidence? The reality tells a different story. DTC Ads Empower Patients Through Education Contrary to popular critiques, DTC advertisements serve as a crucial educational tool, enabling patients to engage more p
Fierce Pharma
JUNE 17, 2025
Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a legislative loophole that drugmakers are allegedly lobbying to retain.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaTimes
JUNE 17, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs FDA approves UroGen’s Zusduri to treat recurrent bladder cancer by Emily Kimber | 17th Jun 2025 | News Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food and Drug Administration (FDA) has approved UroGen Pharma’s Zusduri (mitomycin intravesical solutio
MedCity News
JUNE 19, 2025
Ultimately, the benefits of establishing a data-driven culture reach far beyond improved analytics. It enables a smarter, faster, and more inclusive decision-making process that leads to better care for patients, reduced provider burnout, and stronger financial resilience The post The Benefits of Establishing a Data-driven Culture in Healthcare appeared first on MedCity News.
World of DTC Marketing
JUNE 14, 2025
In June 2025, Senators Bernie Sanders and Angus King introduced legislation to ban direct-to-consumer (DTC) pharmaceutical advertising across all primary media channels, including TV, radio, print, digital platforms, and social media. Their argument? DTC ads are misleading, overly influential, and contribute to rising healthcare costs. The bill reflects a long-standing concern that pharmaceutical companies are too aggressive in marketing prescription drugs to the public, often at the expense of
Fierce Pharma
JUNE 17, 2025
Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory Committee on Immunization Practices and appoint his own replacements, the 17 ousted experts are hitting back at the arguments behind the cull.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
JUNE 16, 2025
Millions of people in the UK will be given the opportunity to take part in clinical trials via the NHS App
MedCity News
JUNE 20, 2025
Those who recognize that AI governance is an innovation enabler will be able to align business priorities and AI investments — and make smarter decisions about which models to accelerate, and which to retire — ultimately leaving the enterprises better positioned to achieve ROI on their AI. The post AI Governance: Building Trust and Transparency for Healthcare AI appeared first on MedCity News.
World of DTC Marketing
JUNE 20, 2025
Low morale within the Food and Drug Administration (FDA) is more than just an internal issue—it sends shockwaves through the pharmaceutical industry, affecting regulatory timelines, decision-making, innovation, and public trust. When morale within such a crucial organization dips significantly, pharma companies should brace for turbulence and prepare for strategic adjustments.
Fierce Pharma
JUNE 16, 2025
With the move, all of Eli Lilly's Zepbound doses will soon be available in cheaper single-dose vials for $499 per month or less.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTimes
JUNE 19, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs eXmoor and Signadori Bio enter cell therapy partnership by Emily Kimber | 19th Jun 2025 | News Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derive
MedCity News
JUNE 15, 2025
Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of Clinical Oncology in Chicago. We covered that news and other developments from the largest cancer conference in the world. The post ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More appeared first on MedCity News.
World of DTC Marketing
JUNE 18, 2025
Search is changing—and fast. For years, pharmaceutical brands poured millions into search engine optimization (SEO), chasing rankings on Google’s first page with keyword-heavy blog posts, backlinks, and meta-tag wizardry. But those strategies are becoming obsolete. The rise of generative AI in search is already reshaping how people find health information.
Fierce Pharma
JUNE 20, 2025
Among its positive recommendations this month, Europe’s CHMP has endorsed marketing authorization for ExCellThera’s Zemcelpro. The medicine is a stem cell transplant treatment for adults with blood cancers that require an allogeneic hematopoietic stem cell transplantation after myeloablative conditioning for whom no other type of suitable donor cells is available.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
pharmaphorum
JUNE 20, 2025
The FDA says it will review clinical trials that send US citizens' cells to 'hostile countries' as leadership at the agency in this area is sidelined.
MedCity News
JUNE 16, 2025
As the adoption of artificial intelligence (AI) advances in healthcare, key considerations can help validate that the technology is purpose-built to help clinicians protect patient safety. The post 6 Questions To Ask Before Integrating AI Into A Clinical Workflow appeared first on MedCity News.
World of DTC Marketing
JUNE 16, 2025
There’s a common belief that eliminating direct-to-consumer (DTC) pharma marketing will significantly reduce drug prices. At first glance, this seems intuitive—no expensive TV ads or digital campaigns surely mean lower drug costs, right? However, the reality is far more nuanced. Prohibiting pharmaceutical direct-to-consumer (DTC) marketing is unlikely to substantially lower drug prices and may have unintended negative consequences, particularly by reducing patient awareness of treatment options.
Fierce Pharma
JUNE 16, 2025
Roche and AbbVie have come up short again in their effort to gain an additional indication for their blockbuster blood cancer treatment Venclexta.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
JUNE 17, 2025
Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient safety and regulatory compliance. AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.
MedCity News
JUNE 17, 2025
This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources. The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared first on MedCity News.
pharmaphorum
JUNE 17, 2025
Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Wh
Fierce Pharma
JUNE 18, 2025
The value of priority review vouchers (PRVs) appears to be on the rise as concerns mount over declining supplies following the sunset of the rare pediatric disease PRV program.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Expert insights. Personalized for you.
259 
Let's personalize your content